Utilizing the correct ICD-10 option will illuminate your way. If you find yourself stuck in the mire when trying to code interleukins and antibodies related to malignant melanomas, figure out a strategy that will put you on the right path. [...]
Untangle your ICD-10 coding options by specifying location and laterality. Are you puzzled when it comes to the interleukins and antibodies related to malignant melanomas? Then you’re not alone. Check out these chemotherapy coding tips, and examine the C codes [...]
Look for specific codes for biologicals, interleukins, and other chemotherapy options. The therapy for malignant melanoma is complex given the chemotherapeutic agents your ongologist may use. Added to these are the interleukins and antibodies that can puzzle even seasoned coders. [...]
Question: How do I choose between V58.11 and V58.12? Illinois Subscriber Answer: Distinguishing chemotherapy from immunotherapy will help you decide whether V58.11 (Encounter for antineoplastic chemotherapy) or V58.12 (Encounter for immunotherapy for neoplastic condition) belongs on your claim. Immunotherapy stimulates [...]
Question: How do I choose between V58.11 and V58.12?Illinois SubscriberAnswer: Distinguishing chemotherapy from immunotherapy will help you decide whether V58.11 (Encounter for antineoplastic chemotherapy) or V58.12 (Encounter for antineoplastic immunotherapy) belongs on your claim.Immunotherapy stimulates the body's ability to fight [...]
Doxorubic and Interferon are at the top of the hit list.Warning: Your already low payments for Part B drugs could wind up slashed even further, if the HHS Office of Inspector General (OIG) gets its way. The OIG has been beating [...]
Doxorubic and Interferon are at the top of the hit listWarning: Your already low payments for Part B drugs could wind up slashed even further, if the HHS Office of Inspector General (OIG) gets its way. The OIG has been [...]
Check with carriers for your statusIn several states, CMS will no longer reimburse for doctor-administered use of intravesical Interferon alpha beyond the first dose. urology practices should be sure to get ABNs to cover the expense if carriers balk at [...]
